Chainalysis reports surge in gray market peptide trade using bitcoin and stablecoins

1 hour ago 2



The gray market for peptides, those injectable compounds promising weight loss, muscle gain, and anti-aging benefits, is booming. And it’s running on crypto.

A Chainalysis report released on June 4, 2026, found that inflows to identified peptide vendors surged from $12 million in Q4 2025 to $32 million in Q1 2026. That’s a 159% increase in a single quarter. Current Q2 pacing suggests inflows could reach $39 million, putting the market on an annualized run rate exceeding $100 million.

From fentanyl to GLP-1 analogs

The viral “looksmaxxing” subculture on TikTok has driven demand for off-label analogs of GLP-1 receptor agonists, the same class of drugs behind Ozempic and Wegovy, with users sharing protocols for stacking various peptides, from weight-loss compounds to growth-hormone secretagogues, often with zero medical supervision.

Chainalysis tracked certain Chinese chemical manufacturers who pivoted from selling fentanyl precursors and amphetamines to direct-to-consumer peptide sales. One example cited in the report: Shanghai Sigma Audley transitioned from fentanyl-precursor sales to peptides using the same contact details and wallets.

Another tracked vendor, Shanghai ERP Peptide Biotechnology, received roughly $3.6 million in digital assets from late January to early June 2026.

Stablecoins win the vendor preference war

The Chainalysis data reveals a clear split in payment preferences based on transaction size. For larger vendors processing average deposits of $1,000 or more, stablecoins have become the dominant payment method over Bitcoin.

The safety problem nobody’s solving

Spending on independent lab testing has plummeted by an estimated 88% per buyer. Even as total testing volume has risen modestly in absolute terms, the ratio of buyers actually verifying what they’re injecting into their bodies has collapsed.

These are injectable compounds. Contamination isn’t a matter of a stomachache. It’s a matter of infections, abscesses, and potentially worse outcomes.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Read Entire Article